The Effect of Acupressure on the Sleep Quality and Daytime Sleepiness
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04800939|
Recruitment Status : Recruiting
First Posted : March 16, 2021
Last Update Posted : April 9, 2021
|Condition or disease||Intervention/treatment||Phase|
|Sleep||Other: Acupressure Other: Plasebo acupressure||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||60 participants|
|Intervention Model:||Parallel Assignment|
|Intervention Model Description:||Prospective, parallel, two-arm, randomized controlled clinical trial|
|Masking Description:||According to the randomization table, the information showing the nurses included in the research sample is assigned to the A and B groups will be put in an opaque envelope. This envelope will be kept by the coordinator researcher (GAU) when the researcher (TÇY), who has an acupressure application certificate, goes to the nurse's application. After filling out the "Informed Consent Form," he will open the envelope and learn which group the nurse is in. Since all nurses included in the study will be applied to the compression point, the participants will be blinded because they do not know that they are a study or control group. The researcher (TÇY), on the other hand, cannot be blinded due to the nature of the research. A statistician will analyze the data, and the findings will be reported.|
|Official Title:||The Effect of Acupressure on the Sleep Quality and Daytime Sleepiness of Surgical Nurses During the COVID-19 Pandemic Process|
|Estimated Study Start Date :||April 5, 2021|
|Estimated Primary Completion Date :||June 22, 2021|
|Estimated Study Completion Date :||July 22, 2022|
Experimental: Acupressure Group
The experimental group will be given acupressure on their own, three times a week for four weeks, one hour before going to bed at night.
The experimental group will start with HT7 points and continue with SP6 points. The application will be carried out by determining the priority order of the points with the draw. Attention will be paid to the intensity and duration of the pressure deemed appropriate. Since the individuals' responses will differ, the stiffness and pressure will be adjusted according to the individual's sensitivity not to cause tissue damage. Before starting the application, around the area to be pressed for 20-30 seconds will be gently rubbed with palm. With the gentle rubbing of the surrounding tissue, the tension and tissue sensitivity in warming, relaxing and preparatory will be reduced, and the tissue will be relieved. After, the point determined will be pressed manually for 2 minutes.
Other Name: Acupress
Placebo Acupressure Group
The control group will be given plasebo acupressure on their own, three times a week for four weeks, one hour before going to bed at night.
Other: Plasebo acupressure
In the control group, the application will start with the points 1.5 cm around the HT7 and SP6 points. The application process will continue in the same way with acupressure group and the pressure intensity will be less.
Other Name: Acupress
- Sleep quality evaluated using the Pittsburgh Quality Sleep Index [ Time Frame: Change from before implementation and 4th week of practice. ]The total scale score is in the range of 0 (minimum) -21 (maximum), and the high total Pittsburgh Quality Sleep Index (PSQI) score indicates that sleep quality is low. A total PSQI score between 0-4 indicates good sleep quality, while between 5-21 shows that sleep quality is low.
- Daytime sleepiness evaluated using the Epworth Sleepiness Scale [ Time Frame: Change from before implementation and 4th week of practice ]This scale, which is a four-point Likert type, aims to evaluate the probability of sleepiness during the individual's daily life between 0-3 points. The scale score is in the range of 0 (minimum) -24 (maximum), and a total Epworth Sleepiness Scale score of 11 or above indicates excessive daytime sleepiness.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04800939
|Contact: Tugba CAM YANIK, Master||+90 324 361 00 01 ext email@example.com|
|Mersin, Yenişehir, Turkey, 33343|
|Contact: Mersin Uni|
|Study Director:||Gulay Altun Ugras, Doctorate||Mersin University|